{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:13:13Z","timestamp":1780585993978,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T00:00:00Z","timestamp":1621728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Urology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ajur.2021.05.005","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T12:51:18Z","timestamp":1622206278000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of desmopressin on frequency and urgency in female patients with overactive bladder and nocturia, current clinical features and outcomes: A systematic review"],"prefix":"10.1016","volume":"9","author":[{"given":"Bara","family":"Barakat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas-Alexander","family":"V\u00f6geli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajur.2021.05.005_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2021.05.005_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajur.2021.05.005_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2021.05.005_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2021.05.005_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/nau.23917","article-title":"An international continence society report on the terminology for nocturia and nocturnal lower urinary tract function","volume":"38","author":"Hashim","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajur.2021.05.005_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.juro.2010.04.011","article-title":"The prevalence and causes of nocturia","volume":"184","author":"Bosch","year":"2010","journal-title":"J Urol"},{"issue":"Suppl 1","key":"10.1016\/j.ajur.2021.05.005_bib7","first-page":"S15","article-title":"Impact of nocturia on sleep and quality of life: A brief, selected review for the International Consultation on Incontinence Research Society (ICI-RS) nocturia think tank","volume":"33","author":"Bliwise","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajur.2021.05.005_bib8","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4111\/kju.2007.48.12.1191","article-title":"Overactive bladder","volume":"48","author":"Lee","year":"2007","journal-title":"Korean J Urol"},{"key":"10.1016\/j.ajur.2021.05.005_bib9","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1471-0528.1997.tb12054.x","article-title":"A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajur.2021.05.005_bib10","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1464-410X.2010.09972.x","article-title":"Outcomes of pharmacological management of nocturia with non-antidiuretic agents: Does statistically significant equal clinically significant?","volume":"107","author":"Smith","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2021.05.005_bib11","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1742-1241.2009.02209.x","article-title":"Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: Results from VIBRANT\u2014a double-blind, placebo-controlled trial","volume":"63","author":"Vardy","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ajur.2021.05.005_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.ju.0000071406.18453.5f","article-title":"Arginine vasopressin and nocturnal polyuria in older adults with frequent nighttime voiding","volume":"170","author":"Johnson","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2021.05.005_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.urology.2005.12.018","article-title":"Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy","volume":"67","author":"Koseoglu","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2021.05.005_bib14","doi-asserted-by":"crossref","first-page":"F1116","DOI":"10.1152\/ajprenal.00741.2010","article-title":"Gender difference in antidiuretic response to desmopressin","volume":"300","author":"Juul","year":"2011","journal-title":"Am J Physiol Ren Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.ajur.2021.05.005_bib15","first-page":"S6","article-title":"Renal physiology of nocturia","volume":"33","author":"Verbalis","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajur.2021.05.005_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/nau.20613","article-title":"Desmopressin, as a \"designer-drug\", in the treatment of overactive bladder syndrome","volume":"28","author":"Hashim","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajur.2021.05.005_bib17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1464-410X.2004.04768.x","article-title":"Antidiuresis: A new concept in managing female daytime urinary incontinence","volume":"93","author":"Robinson","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2021.05.005_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajur.2021.05.005_bib19","doi-asserted-by":"crossref","first-page":"E770","DOI":"10.5489\/cuaj.3097","article-title":"Effects of desmopressin for the treatment of nocturnal polyuria in elderly women: Impact on related sleep quality","volume":"9","author":"Mun","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.ajur.2021.05.005_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4111\/kju.2013.54.2.95","article-title":"Influence of type of nocturia and lower urinary tract symptoms on therapeutic outcome in women treated with desmopressin","volume":"54","author":"Jeong","year":"2013","journal-title":"Korean J Urol"},{"key":"10.1016\/j.ajur.2021.05.005_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/luts.12169","article-title":"Low-dose desmopressin and tolterodine combination therapy for treating nocturia in women with overactive bladder: A double-blind, randomized, controlled study","volume":"10","author":"Rovner","year":"2018","journal-title":"Low Urin Tract Symptoms"},{"key":"10.1016\/j.ajur.2021.05.005_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4111\/kju.2011.52.6.396","article-title":"Effect of desmopressin with anticholinergics in female patients with overactive bladder","volume":"52","author":"Han","year":"2011","journal-title":"Korean J Urol"},{"key":"10.1016\/j.ajur.2021.05.005_bib23","doi-asserted-by":"crossref","first-page":"878564","DOI":"10.1155\/2013\/878564","article-title":"Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index","volume":"2013","author":"Hajdinjak","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ajur.2021.05.005_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/nau.20168","article-title":"Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia","volume":"25","author":"Rembratt","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajur.2021.05.005_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/ijcp.12786","article-title":"Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice","volume":"70","author":"Chen","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ajur.2021.05.005_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0090-4295(01)01645-4","article-title":"Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years","volume":"59","author":"Kuo","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2021.05.005_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.juro.2007.03.042","article-title":"The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: A circadian study","volume":"178","author":"Bae","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2021.05.005_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.eururo.2012.10.048","article-title":"Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a \u03b2(3)-adrenoceptor agonist, in overactive bladder","volume":"63","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2021.05.005_bib29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/nau.22645","article-title":"Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a \u03b23-adrenoceptor agonist, in patients with overactive bladder in Asia","volume":"34","author":"Kuo","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajur.2021.05.005_bib30","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bju.12649","article-title":"Phase III, randomised, double-blind, placebo-controlled study of the beta3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder","volume":"113","author":"Yamaguchi","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2021.05.005_bib31","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00192-013-2042-x","article-title":"A phase II dose-ranging study of mirabegron in patients with overactive bladder","volume":"24","author":"Chapple","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.ajur.2021.05.005_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/ijcp.12194","article-title":"Mirabegron for the treatment of overactive bladder: A prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies","volume":"67","author":"Nitti","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ajur.2021.05.005_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1464-410X.2002.02791.x","article-title":"Efficacy of desmopressin in the treatment of nocturia: A double-blind placebo-controlled study in men","volume":"89","author":"Mattiasson","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2021.05.005_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.eururo.2007.01.027","article-title":"Desmopressin in the treatment of nocturia: A double-blind, placebo-controlled study","volume":"52","author":"Van Kerrebroeck","year":"2007","journal-title":"Eur Urol"}],"container-title":["Asian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388221000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388221000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:33:57Z","timestamp":1762000437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214388221000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2214388221000424"],"URL":"https:\/\/doi.org\/10.1016\/j.ajur.2021.05.005","relation":{},"ISSN":["2214-3882"],"issn-type":[{"value":"2214-3882","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of desmopressin on frequency and urgency in female patients with overactive bladder and nocturia, current clinical features and outcomes: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajur.2021.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}